Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis
Frontiers in Behavioral Neuroscience · 05.01.2023 · 16
DOI: 10.3389/fnbeh.2022.1068736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Behavioral Neuroscience, online erschienen am 05.01.2023. Verfasst von Kholoud M Al-Otaibi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education – Kingdom of Saudi Arabi.
Abstract (Originalsprache)
Stimulation of remyelination is critical for the treatment of multiple sclerosis (MS) to alleviate symptoms and protect the myelin sheath from further damage. The current study aimed to investigate the possible therapeutic effects of combining vitamin D3 (Vit D3) and siponimod (Sipo) on enhancing remyelination and modulating microglia phenotypes in the cuprizone (CPZ) demyelination mouse model. The study was divided into two stages; demyelination (first 5 weeks) and remyelination (last 4 weeks). In the first 5 weeks, 85 mice were randomly divided into two groups, control ( n = 20, standard rodent chow) and CPZ ( n = 65, 0.3% CPZ mixed with chow for 6 weeks, followed by 3 weeks of standard rodent chow). At week 5, the CPZ group was re-divided into four groups ( n = 14) for remyelination stages; untreated CPZ (0.2 ml of CMC orally), CPZ+Vit D3 (800 IU/kg Vit D3 orally), CPZ+Sipo (1.5 mg/kg Sipo orally), and CPZ+Vit D3 (800 IU/kg Vit D3) + Sipo (1.5 mg/kg Sipo orally). Various behavioral tasks were performed to evaluate motor performance. Luxol Fast Blue (LFB) staining, the expression level of myelin basic protein (MBP), and M1/M2 microglia phenotype genes were assessed in the corpus callosum (CC). The results showed that the combination of Vit D3 and Sipo improved behavioral deficits, significantly promoted remyelination, and modulated expression levels of microglia phenotype genes in the CC at early and late remyelination stages. These results demonstrate for the first time that a combination of Vit D3 and Sipo can improve the remyelination process in the cuprizone (CPZ) mouse model by attenuating the M1 microglia phenotype. This may help to improve the treatment of MS patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Chemistry, Faculty of Science, Albaha University, Albaha, Saudi Arabia.
- Department of Physiology, Neuroscience Unit, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
- Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Vitamin D Pharmacogenomics Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
- Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Förderung
- Ministry of Education – Kingdom of Saudi Arabi
Zitieren
APA
Al-Otaibi, K. M., Alghamdi, B. S., Al-Ghamdi, M. A., Mansouri, R. A., Ashraf, G. M., & Omar, U. M. (2023). Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis. Frontiers in Behavioral Neuroscience, 16. https://doi.org/10.3389/fnbeh.2022.1068736
Vancouver
Al-Otaibi KM, Alghamdi BS, Al-Ghamdi MA, Mansouri RA, Ashraf GM, Omar UM. Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis. Frontiers in Behavioral Neuroscience. 2023;16. doi:10.3389/fnbeh.2022.1068736
BibTeX
@article{AlOtaibi2023,
author = {Al-Otaibi, Kholoud M and Alghamdi, Badrah S and Al-Ghamdi, Maryam A and Mansouri, Rasha A and Ashraf, Ghulam Md and Omar, Ulfat M},
title = {Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis},
journal = {Frontiers in Behavioral Neuroscience},
year = {2023},
volume = {16},
doi = {10.3389/fnbeh.2022.1068736}
}
EUVIMED